Immunic, Inc.IMUXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.7%
5Y CAGR+15.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+11.7%/yr
vs +3.0%/yr prior
5Y CAGR
+15.5%/yr
Recent deceleration
Acceleration
+8.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$21.25M+18.0%
2024$18.01M+12.5%
2023$16.01M+4.9%
2022$15.26M+14.8%
2021$13.30M+28.7%
2020$10.33M-28.8%
2019$14.52M+6.9%
2018$13.59M+2.0%
2017$13.31M+18.7%
2016$11.22M-